Clinical Trial

Effect of Huaier Granule on the Treatment of Idiopathic Membranous Nephropathy

Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
This is a prospective, multicenter, randomized, open-label, parallel controlled study. The purpose of this study is to evaluate the efficacy and safety of Huaier granule on the treatment of idiopathic membranous nephropathy comparing with Ciclosporin soft capsules.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2023-04-20; most recent amendment 2024-06-02.
Status change: Not Yet Recruiting → Recruiting 2023-12-26
Trial Details
NCT Number NCT05839314
Lead Sponsor Chinese PLA General Hospital
Collaborators: LinkDoc Technology (Beijing) Co. Ltd., Huazhong University of Science and Technology
Conditions Nephropathy, Glomerular Diseases, Idiopathic Membranous Nephropathy
Enrollment 480 participants
Start Date 2023-05-09
Primary Completion 2027-05-03 (estimated)
Study Completion 2027-07-01 (estimated)
Updated on ClinicalTrials.gov 2024-06-04